Daily BriefsUnited States

Daily Brief United States: TômTex Co, Aspira Women’s Health, VanEck Gold Miners ETF/USA and more

In today’s briefing:

  • TômTex secures US$4.15M to make eco-friendly textiles | e27
  • Aspira Women’s Health, Inc. – Secures Important Reimbursements
  • Continue to Ride the Trend Higher; Buying Gold, Silver, Miners $GDX $GDXJ $GLD $SLV


TômTex secures US$4.15M to make eco-friendly textiles | e27

By e27

  • New York-based biomaterial company TômTex has secured US$4.15 million in a seed investment round led by Happiness Capital.
  • Earth Venture Capital, SOSV, Parley for the Oceans, and MIH Capital also participated.
  • The funding will support the growth of TômTex’s Brooklyn team, fill key leadership roles, and enhance manufacturing capabilities.

Aspira Women’s Health, Inc. – Secures Important Reimbursements

By Water Tower Research

  • Aspira Women’s Health made two reimbursement announcements this week.
  • On November 27, Aspira announced that the Centers for Medicare and Medicaid Services (CMS) approved the crosswalk of the fee to be paid to the company for OvaWatch to the fee paid historically for Ova1.
  • Aspira will be reimbursed at a rate of $897 for all OvaWatch and Ova1 tests processed for Medicare patients meeting applicable coverage requirements beginning on January 1, 2024. 

Continue to Ride the Trend Higher; Buying Gold, Silver, Miners $GDX $GDXJ $GLD $SLV

By Joe Jasper

  • Discussed risk/reward favored buyers in late-October as supports were being tested (October 24 and 31), then we outlined on 11/7/23 our belief that a significant year-end rally was likely underway.
  • New market-generated information has continued to be risk-on, which has only reinforced our bullish outlook on the broad equity market.  We continue to expect a rally into year-end and beyond
  • Gold and silver are bullishly inflecting, and we are buying GLD, SLV, and the miners (GDX, GDXJ)

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars